Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poenaru

Showing results (471-480 of 475) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 475 results.
American Heart Journal|October 11, 2020
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)Henrik Wiggers, Lars Køber, Gunnar Gislason, et al.
The New England Journal of Medicine|September 1, 2025
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Anna Meta D Kristensen, Sigrun Halvorsen, et al.
Lancet (London, England)|May 7, 2014
Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Nicholas J Kassebaum, Amelia Bertozzi-Villa, Megan S Coggeshall, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Lancet (London, England)|September 15, 2015
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Mohammad H Forouzanfar, Lily Alexander, et al.
Pageof 48

Showing results (471-480 of 475) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 475 results.
American Heart Journal|October 11, 2020
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)Henrik Wiggers, Lars Køber, Gunnar Gislason, et al.
The New England Journal of Medicine|September 1, 2025
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Anna Meta D Kristensen, Sigrun Halvorsen, et al.
Lancet (London, England)|May 7, 2014
Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Nicholas J Kassebaum, Amelia Bertozzi-Villa, Megan S Coggeshall, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Lancet (London, England)|September 15, 2015
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Mohammad H Forouzanfar, Lily Alexander, et al.
Pageof 48